Biopharma

RIFTOVAC

Live attenuated and freeze-dried vaccine (Clone 13 strain) for the vaccination of cattle, sheep,

goats and camelids against Rift Valley fever.

Suspension of attenuated Rift Valley fever virus strain designated thermostable clone 13

“C13 TS-D10”:

Minimum quantity by  ovine and caprine dose: At least 104.0 DICT 50 by dose.

Minimum quantity by bovine and camel dose: At least 105.0 DICT 50 by  dose

Pharmaceutical form:
Suspension injectable.

Indications:

Active immunization of cattle, sheep, goats and

camels against Rift Valley fever

Administration:

Subcutaneous route.

Presentation

Vaccine (Lyophilisate)

Sheep and goats:

Bottle of 100 doses at 105.7 DICT 50/ml.

Bottles of 50 doses at 105.4 DICT 50/ml.

Cattle and camels:

Bottle of 50 doses at 106.4 TCID50/ml.

Bottles of 25 doses at 106.1 TCID50 /ml

Diluted

Bottles of 50 and 100 ml, depending on the viral titer obtained for the

lyophilisate and according to the dosage